Caisse Des Depots ET Consignations Invests $1.68 Million in DaVita Inc. (NYSE:DVA)

Caisse Des Depots ET Consignations acquired a new position in DaVita Inc. (NYSE:DVA) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 11,250 shares of the company’s stock, valued at approximately $1,682,000.

Other large investors have also recently made changes to their positions in the company. UniSuper Management Pty Ltd grew its holdings in DaVita by 21.8% during the 4th quarter. UniSuper Management Pty Ltd now owns 11,506 shares of the company’s stock worth $1,721,000 after acquiring an additional 2,063 shares in the last quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund purchased a new stake in shares of DaVita during the fourth quarter worth about $449,000. Financial Engines Advisors L.L.C. grew its position in DaVita by 2.7% during the 4th quarter. Financial Engines Advisors L.L.C. now owns 15,112 shares of the company’s stock worth $2,260,000 after purchasing an additional 403 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp increased its position in shares of DaVita by 15.3% in the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 128,528 shares of the company’s stock valued at $19,221,000 after acquiring an additional 17,008 shares during the period. Finally, Del Sette Capital Management LLC acquired a new position in shares of DaVita in the fourth quarter valued at about $1,254,000. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Stock Performance

DaVita stock opened at $152.73 on Friday. The stock has a market cap of $12.22 billion, a price-to-earnings ratio of 14.22, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The firm has a 50 day simple moving average of $157.71 and a 200-day simple moving average of $157.50. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Barclays increased their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on DaVita in a research report on Friday, February 21st. StockNews.com downgraded shares of DaVita from a “buy” rating to a “hold” rating in a research report on Friday, March 21st. Finally, Cowen reissued a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.